Octean Pharma ApS: Financial statements 2021
CVR: 38023667
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,193,102 and a net result of DKK 42,977 compared with DKK 11,061 the year before. That is an increase of 50.4% compared with the year before. Equity in the 2021 report amounted to DKK 90,154. The solvency ratio was 9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,193,102
- Profit/Loss
- DKK 42,977
- Equity
- DKK 90,154
- Total Assets
- DKK 997,346
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.2 mio. | 43 t. | 90 t. | 1 |
| 2020 | 1.3 mio. | 793 t. | 11 t. | 47 t. | 1 |
| 2019 | 1.1 mio. | 751 t. | 51 t. | 36 t. | - |
| 2018 | 844 t. | 584 t. | 97 t. | -15 t. | - |
Official annual report
Find more companies like Octean Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Octean Pharma ApS has published its annual report for 2020. Revenue came to DKK 1,330,642, and the net result was DKK 11,061.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.